Market Overview

Mid-Day Market Update: Crude Oil Down Around 2%; Zosano Pharma Shares Spike Higher


Midway through trading Monday, the Dow traded up 0.55 percent to 20,381.17 while the NASDAQ gained 0.46 percent to 5,760.25. The S&P also rose, gaining 0.39 percent to 2,325.08.

Leading and Lagging Sectors

Basic materials shares climbed by 1.14 percent in trading on Monday. Meanwhile, top gainers in the sector included Vale SA (ADR) (NYSE: VALE), and Intrepid Potash, Inc. (NYSE: IPI).

In trading on Monday, telecommunications services shares fell by 0.43 percent. Meanwhile, top losers in the sector included NQ Mobile Inc (ADR) (NYSE: NQ), down 6 percent, and J2 Global Inc (NASDAQ: JCOM), down 2 percent.

Top Headline

Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) reported better-than-expected results for its fourth quarter, driven by the acquisition of Actavis Generics business. The company also reaffirmed its 2017 outlook, which also came in above consensus expectations.

Teva posted Q4 earnings of $1.38 per share on revenue of $6.49 billion. Analysts were expecting earnings of $1.35 per share on revenue of $6.25 billion.

Equities Trading UP

Zosano Pharma Corp (NASDAQ: ZSAN) shares shot up 73 percent to $2.08 after the company disclosed that M207 has achieved both co-primary endpoints in ZOTRIP pivotal efficacy migrane trial.

Shares of Sino-Global Shipping America, Ltd. (NASDAQ: SINO) got a boost, shooting up 79 percent to $4.88. Sino-Global reported Q2 earnings of $0.11 per share on revenue of $2.129 million.

Trio-Tech International (NYSE: TRT) shares were also up, gaining 14 percent to $4.36. On Friday, Trio-Tech reported Q2 earnings of $0.09 per share on revenue of $9.1 million.

Equities Trading DOWN

Hain Celestial Group Inc (NASDAQ: HAIN) shares dropped 11 percent to $34.26 after the company announced a SEC subpoena seeking documents related to delayed filing.

Shares of X T L Biopharmaceuticals Ltd (ADR) (NASDAQ: XTLB) were down around 14 percent to $2.58. XTL Biopharmaceuticals disclosed that it has expanded its clinical advisory board to support Phase II trial of HCDR1 in Sjogren's syndrome.

Knoll Inc (NYSE: KNL) was down, falling around 11 percent to $24.07. Knoll Inc. on Friday posted Q4 earnings of $21.4 million on revenue of $292.9 million.


In commodity news, oil traded down 1.97 percent to $52.80 while gold traded down 1.01 percent to $1,223.40.

Silver traded down 0.57 percent Monday to $17.83, while copper rose 0.96 percent to $2.79.


European shares were higher today. The eurozone’s STOXX 600 rose 0.88 percent, the Spanish Ibex Index rose 1.19 percent, while Italy’s FTSE MIB Index surged 1.23 percent. Meanwhile the German DAX climbed 1.08 percent, and the French CAC 40 rose 1.55 percent while U.K. shares rose 0.41 percent.


On the economics calendar Monday, there is no important data due out.

Posted-In: Earnings News Eurozone Commodities Global Intraday Update Markets Movers


Related Articles (HAIN + IPI)

View Comments and Join the Discussion!

Goldman Previews Arista, NetApp, Zebra Tech Earnings; Prefers NetApp

Analysts Split On How To Read Intercept Switching Clinical Trial Endpoints